A carregar...
nab-Paclitaxel for the treatment of pancreatic cancer
BACKGROUND: Nanoparticle albumin-bound paclitaxel (nab-P) plus gemcitabine (Gem) became a standard treatment option for metastatic pancreatic cancer (MPC) following positive results from a global phase III trial (MPACT). A large number of studies have now published results on the use of nab-P/Gem to...
Na minha lista:
| Publicado no: | Cancer Manag Res |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5360414/ https://ncbi.nlm.nih.gov/pubmed/28356771 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S127840 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|